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Unprimed T  cells transferred to heavily irradiated H-2-compatible mice cause a 
high incidence of lethal graft-vs.-host disease (GVHD)a in certain strain combinations 
(1-3). GVHD in this setting is a  consequence of mature post-thymic donor T  cells 
responding to the multiple minor histocompatibility antigen (minor HA) differences 
of the host. With the combination of CBA and B10.BR (both H-2~), doses of as few 
as  106 CBA T  cells regularly kill close to  100% of irradiated B10.BR mice. Recent 
studies with this strain combination demonstrated that T  cells eliciting lethal GVHD 
to minor HA are subject to H-2-restriction (4). To examine this question, CBA T cells 
were reeirculated through  irradiated mice of the B10 H-2 congenic lines and  then 
tested for their capacity to kill B10.BR mice. When CBA T  cells were filtered from 
blood to lymph for  1 d  through irradiated B10.BR or H-2-semisyngeneic (CBA  × 
B10)F1 mice, negative selection occurred, i.e., the filtered T  cells failed to kill B10.BR 
mice on further transfer.  Selection was  not  apparent,  however, when CBA T  cells 
were filtered through totally H-2-different irradiated mice, e.g., B10 (H-2°), B10.D2 
(H-2a), or B 10.S (H-if). Selection thus depended upon a sharing of H-2 determinants 
between the donor and host. 
These findings raised a number of questions, including: (a) What is the relationship 
between  T  cells  causing  GVHD  to  minor  HA  and  minor  HA-specific  cytotoxic 
lymphocytes  (CTL)?  (b)  Do  GVHD-indueing T  cells,  like CTL,  comprise discrete 
subgroups of H-2K- and H-2D-restricted cells? (c) Are H-2I-restricted cells involved 
in GVHD to minor HA? (d) What cells present minor HA to T  cells during negative 
selection?  (e)  Is  antigen  processing involved during negative selection? This paper 
attempts to provide answers to these questions. 
Materials and Methods 
Mice.  CBA/J (CBA), B10.BR/SgSn (B10.BR), C57BL/10J (B10), C57BL/6J, (B6), BI0.D2, 
and B10.A mice were purchased from The Jackson Laboratory, Bar Harbor, ME. B10.OL and 
B10.TL mice were kindly provided by C. David, Mayo Clinic, Rochester, MN. B10.S, A.TH, 
and  B10.S(7R)  mice  were  donated  by  Dr.  B.  Knowles,  The Wistar  Institute.  (B10.A  × 
B10.OL)F1 mice were bred  in  our own  colony.  (B6  ×  CBA)F1 mice  were obtained  from 
* Supported by research grants CA-09140,  CA-15822,  AI-10961,  and AI-15412 from the U. S. Public 
Health Service. 
1 Abbreviations used in  this paper:  GVHD,  graft-vs.-host disease;  minor HA,  minor histocompatibility 
antigens;  CTL,  cytotoxic  lymphocytes;  C',  complement;  BM,  bone marrow;  LN,  lymph  node;  TDL, 
thoracic duct lymphocytes; MST, median survival time; IL-2, interleukin 2. 
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Cumberland View Farms, Clinton, TN,  and  (B6  X  C3H/He)F1  mice were purchased  from 
Simonsen Laboratories, Gilroy, CA. Male mice were used as cell donors, filtration hosts, and 
recipients. 
Media.  RPMI 1640 (Microbiological Associates, Walkersville, MD) supplemented with 2% 
fetal calf serum was used. 
Injections.  Unless stated otherwise, all cell suspensions were given intravenously via the tail 
vein in a volume of 0.5-1.0 ml. 
Reagents.  A.TH anti-A.TL antiserum (anti-Ia  k) and monoclonal anti-Lyt- 1.1 antibody were 
purchased from Accurate Chemical & Scientific Corp, Westbury, NY.  Monoclonal rat anti- 
mouse  Lyt-2  antibody,  which  detects  a  monomorphic  determinant,  was  produced  in  our 
laboratory from hybridoma cells kindly donated by F. Fitch, University of Chicago, Chicago, 
IL. Monoclonal anti-Thy-l.2 (Jlj) (IgM) antibody was made in this laboratory (5). Hybridoma 
10-3.6  (IgG2a)  detects  a  public  I-A specificity (Ia.17),  whereas  hybridoma  11-5.2  (IgG2b) 
detects a private I-A specificity (Ia.2) (6). Hybridomas 10-3.6 and 11-5.2 were made available 
by the Herzenberg group, Stanford University School of Medicine, Stanford, CA. Hybridoma 
antibody CE636 (IgM) detects a public I-E specificity (Ia.7) and was kindly provided by F. W. 
Symington, University of Pennsylvania, Philadelphia, PA.  (7).  Antibody titers of the mono- 
clonal reagents ranged from 104 to l0  b. Guinea pig and rabbit complement (C') were prepared 
in our own laboratory. 
Preparation of Cells.  Suspensions of bone marrow  (BM)  cells and  lymph node(LN)  cells 
(pooled from mesenteric, axillary, inguinal, and  cervical nodes)  were prepared as described 
previously (4).  LN cells were treated with  A.TH  anti-A.TL antisera  (1:4 final dilution) or 
monoclonal anti-Lyt-I.  1 (1:20)  in a two-step procedure involving incubation of_< 108 cells with 
antibody in 2 ml for 30 min at 4°C, washed once, and incubated at 37°C for 40 rain in 5 ml 
with a mixture of guinea pig (1:10) and rabbit (1:60) C'. Treatment of cells with anti-Lyt-2 (1: 
10), anti-Thy- 1.2  (1:25)  antibody, or with a  mixture of anti-Ia antibodies [anti-Ia. 17  (1:25), 
anti-Ia.2 (1:25), and anti-Ia.7 (1:50)] were performed in a single step in 5-ml vol at 37°C for 40 
min with guinea pig C' (1:5)  or with a mixture of rabbit and guinea pig C'. 
Irradiation.  Mice were exposed to ~SVCs-y-irradiation at a dose of ~ 100 tad/rain. 
Negative Selection to Minor HA.  The  filtration procedure was  identical to  that  previously 
described (4). In brief, 1 ×  108 to 2 ×  108 LN cells were injected intravenously into irradiated 
(850  rad)  hosts, and  thoracic duet lymphocytes (TDL)  were collected between  18 and 40 h 
later. TDL were pooled from two to three mice per group. 
Mortality Assay for GVHD.  As previously described (1, 4), 2- to 4-mo-old B10.BR mice were 
exposed  to  a  midlethal  dose  of irradiation  (750  rad)  and  then  -6  h  later were  injected 
intravenously with a  mixture of T  cell-depleted CBA BM  (4  ×  106 viable cells treated with 
anti-Thy-l.2 antibody and C'), together with the test population of CBA T  cells (either TDL 
or normal LN). Recipients of marrow cells alone served as controls. 
Statistical  Analysis.  Median  survival  times  (MST)  and  comparison  between  individual 
groups were calculated as previously described (4). 
Preparation of Bone Marrow Chimeras.  As described elsewhere (8), chimeras were prepared by 
transferring 5 ×  108 to 10 ×  l0  s anti-Thy-l.2 plus C'-treated marrow cells intravenously into 
mice exposed to 750-1,100 rad 4-6 h  previously. Double chimeras were prepared by reconsti- 
tuting irradiated (1,100  rad) (B6 ×  CBA)F1 mice with a mixture of 5 X  106 CBA marrow plus 
107 B10 marrow  (more of the latter cells were injected because B10 cells are subject to Hh 
resistance). In the case of H-2-incompatible combinations, appropriate anti-H-2 sera were used 
to establish the degree of lymphoid cell chimerism (8). Cage mates of the chimeras used for 
selection at 6-11 mo postreconstitution contained virtually no (<1%) host cells. Double chimeras 
contained 40-60% of each donor marrow population and no detectable host cells. 
Results 
Experimental  Design.  To  induce  negative  selection,  large  doses  of CBA  LN  cells 
were  injected  intravenously into  heavily irradiated mice,  and  the donor  cells were 
collected from TDL of the recipients 18-40 h  post-transfer. Small doses of the filtered 
T  cells  (usually  106) were  then  transferred  with  anti-Thy-l.2-treated CBA  marrow 874  H-2  RESTRICTION  OF  GRAFT-VS.-HOST  DISEASE 
cells  into  lethally  irradiated  (750  rad)  B10.BR  mice  (see Materials  and  Methods). 
Mortality of the recipients was studied over 80-100 d. Recipients of marrow cells but 
not T  cells served as controls; scattered deaths occurred in these control groups within 
the first 4 wk post-transfer but were rare thereafter. 
Separation of H-2K- and H-2D-restricted  T Cells by Double Negative Selection.  In previous 
studies  (4), it was shown  that a  complete sharing of H-2 determinants between the 
donor T  cells and the selection host was required to obtain negative selection (a failure 
of the  filtered  T  cells  to  kill  B10.BR  mice).  Thus,  irrespective  of whether  CBA 
(Kkl~D  k) (kkk) T  cells were filtered through irradiated K/I-matched B10.A (kkd) mice 
or D,  matched B10.OL (ddk) mice, the cells retained the capacity to kill close to 100% 
of B10.BR mice; effective selection occurred in (B10.A ×  B10.OL)Fa mice. To explain 
these  findings,  it was suggested  that  CBA T  cells might  comprise a  roughly 50:50 
mixture of subsets of K- and D-restricted T  cells;  filtration of the cells through, e.g., 
B10.A  mice, would  remove the K-restricted cells but  not  the D-restricted cells and 
thereby reduce the GVHD-inducing potency of the cells by a factor of ~2, a difference 
that is beyond the sensitivity of the GVHD mortality assay. 
To seek direct support  for this  interpretation,  we examined  the effects of double 
negative  selection  through  B10.OL  and  B10.A  mice  (Fig.  1).  CBA  LN  cells  were 
recirculated  through  large numbers of B10.OL  mice and  divided  into  two  groups. 
One-half of the cells were recirculate  d  through  B 10.A mice, whereas the other one- 
half were recirculated  for a  second time through B10.OL mice. As shown in Fig.  1, 
the  capacity  of CBA  T  cells  to  kill  B10.BR  mice  after  double  selection  through 
B 10.OL mice was similar to that of control cells filtered once through syngeneic CBA 
mice.  By contrast,  CBA T  cells  filtered  first  through  B10.OL  (ddk) mice and  then 
through B 10.A (kkd) mice failed to cause GVHD. The mortality rate with these cells 
was no higher than in mice given T  cells filtered through  (B10.A ×  B10.OL)Fx mice 
or in control mice given marrow cells but  no T  cells;  in each of these three groups 
there were no deaths after day 35. These data imply that non-cross-reactive subsets of 
K- and D-restricted T  cells are the principal effector cells for GVHD induction. 
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Fro.  1.  Separation of H-2K- and H-2D-restricted T  cells by double negative selection. The data 
show mortality in irradiated  (750 rad) B10.BR mice given T  cell-depleted CBA BM plus 106 CBA 
(kkk) T  cells, recirculated once through B 10.OL (ddk) mice and then once through B 10.A (kkt  0 mice 
(B10.OL then B10.A) or twice through B10.OL mice (BI0.OL then Bt0.OL, MST 24.5 +  1.0 d). 
Control T  cells were filtered once through CBA (MST 14.9 d=  1.4 d) or (B10.A ×  B10.OL)F1 mice. 
Data from a single experiment involving six to seven mice per group. ROBERT  KORNGOLD AND JONATHAN  SPRENT  875 
Failure of I-restricted T  Cells to Mediate G VHD.  In the case of T helper cells, exposure 
to antigen during recirculation through H-2I-matched irradiated hosts is an effective 
method for producing negative selection of I-restricted T  cells (9). The fact that CBA 
T cells retain their GVHD potency after filtration through I-A/B/J/E-matched B 10.A 
mice (which should remove K- and I-restricted cells but not D-restricted cells)  (4, see 
above)  argues against  the view that  minor HA-specific, I-restricted T  cells play an 
obligatory role in GVHD induction, e.g., by acting as T  helper cells (see Discussion). 
The possibility that I-restricted T  cells themselves might mediate GVHD, however, 
has not  been excluded.  Testing this  possibility necessitates  determining whether T 
cells can mediate GVHD after prior removal of the K/D-restricted subsets. In theory, 
this could be done by filtering CBA T  cells through B 10 congenic mice of the K*ffD  k 
haplotype. Because mice of this haplotype have not been described, we turned to a 
different  H-2-compatible minor  HA-disparate strain  combination,  viz.,  A.TH and 
B10.S(7R)  (both/¢/~Da). 
As for the combination of CBA and B10.BR mice, A.TH T  cells filtered through 
syngeneic  A.TH  mice  caused  severe  mortality  when  transferred  to  irradiated 
B10.S(7R)  mice  (Table  I).  Lethal  GVHD  in  B10.S(7R)  mice  also  occurred  with 
passage of A.TH (ssd) T  cells through K/I-matched, D-mismatched B 10.S  (sss) mice 
or  through  D-matched,  K/I-mismatched  B10.D2  (ddd)  mice  (for obscure  reasons, 
GVHD was less severe with filtration through B 10.S mice than with filtration through 
B10.D2  mice)i  Significantly,  A.TH T  cells  filtered  through  K- and  D-matched,  I- 
mismatched B t0.TL  (skd)  mice, which would be expected to remove K/D-restricted 
T  cells but not I-restricted cells, failed to cause GVHD; with these cells there were no 
deaths after day 30. 
These data suggest that I-restricted T  cells per se do not induce GVHD. Studies on 
the Lyt phenotype of GVHD-inducing T  cells, considered below, support this view. 
Lyt Phenotype of T  Cells Causing Anti-Minor HA  G VHD.  It is generally accepted that 
I-restricted T  cells have the Lyt-l÷2  -  phenotype, whereas K/D-restricted T  cells are 
either  Lyt-l-2  + or  Lyt-l+2  +  (10,  13).  From  the  above findings  (Table I), it  would 
therefore follow that pretreatment ofT cells with anti-Lyt-2 antibody and complement 
TAULE  I 
Failure of A. TH  T  Cells to Kill H-2-compatible Irradiated BIO.S(7R)  Mice after Filtration through 
K/D-matched, I-mismatched BIO. TL Mice 
Selection host for 
A.TH T cells 
H-2 haplotype 
I 
Mortality in B10.S(7R) mice* 
K  A  B  J  E  C  S  D  Dead/  Percent  MST (:1: SE) 
total  dead 
d 
A.TH  s  s  s  s  s  s  s  d  10/12  83  24.2:1:1.2 
B10.S(7R)  s  s  s  s  s  s  s  d  2/12  17  >lO0.O 
B10.TL  s  k  k  k  k  k  k  d  2/12  17  >100.0 
B10.D2  d  d  d  d  d  d  d  d  6/6  100  25.8:1:1.2 
B10.S  s  s  s  s  s  s  s  s  6/9  67  59.8 +  1.3 
BM alone  2/12  17  >100.0 
Irradiation alone  3/3  100  16.5 +  1.1 
* Irradiated (750 rad) B10.S(7R) mice given 5 X 106 T cell-depleted A.TH BM cells plus 108 A.TH T cells 
filtered from blood to lymph for 1 d through irradiated (900 rad) mice of various strains. Data were 
pooled from  two separate experiments. 876  H-2  RESTRICTION  OF  GRAFT-VS.-HOST  DISEASE 
TABLE  II 
Surface Antigen Phenotype of T Cells Causing Anti-Minor HA GVHD 
Number of viable  Mortality in B10.BR mice* 
CBA LN cells  Pretreatment of CBA LN cells  transferred to Jr-  in vitro  Percent  radiated B 10.BR  Dead/total 
mice ( ×  10  -c')  dead 
MST ±  SE 
None 
d 
20  10/10  100  18.2 ±  1.2 
5  29/31  94  21.9 ±  1.1 
2  18/18  100  29.3 ±  1.l 
1  4/6  67  51.8 ±  1.9 
aLyt-2 +  C'  20  2/12  18  >100.0 
5  7/28  25  >100.0 
2  4/18  22  >100.0 
aLyt-l.1 +  C'  5  13/13  100  19.5 ±  1.1 
2  5/6  83  29.3 ±  1.7 
1  3/6  50  85.7 ±  2.3 
aLyt-l.1 +  C'  5  14/20  70 
(double treatment) 
58.0 ±  1.1 
aIa  k (A.TH otA.TL antiserum)  5  8/8  100  17.1 ±  I. 1 
+  C'  2  6/6  100  17.3 ±  1.8 
otIa  * (mixture ofaIa.2,  5  15/15  100  22.3 ±  1.1 
aIa.17 and aIa.7) +  C'  2  6/6  100  16.7 +  1.2 
1  6/9  67  38.5 +  1.7 
aThy-l.2 +  C'  20  1/9  11  >100.0 
aThy-l.2 -  C'  20  3/12  25  >100.0 
Marrow alone  4/27  15  > 100.0 
Irradiation alone  18/22  82  18.7 ±  1.2 
* Irradiated (750 rad) B10.BR mice given T  cell-depleted CBA BM together with normal CBA LN cells 
(50-60% Thy-l.2  +) treated with alloantibody and C' in vitro. Cytotoxic indices with respect to T  (Thy- 
1.2  +) cells were anti-Lyt-2, 20-40%; anti-Lyt-1.1, ->95% (for both single and double treatment); anti-Ia, 
--<5%. Data  were  pooled  from  four  experiments.  All  antibodies  used  were  monoclonal  (hybridoma) 
reagents unless stated otherwise. 
would abolish the capacity of the surviving cells to mediate  GVHD.  This was indeed 
found  to be the case.  CBA  LN cells, surviving treatment  with monoclonal  anti-Lyt-2 
antibody  plus C', failed to cause GVHD  in B10.BR  mice, even with cell doses as high 
as  2  ×  107  viable  cells  (Table  II).  Interestingly,  pretreatment  of  LN  cells  with 
monoclonal  anti-Lyt-l.1  antibody  plus  C',  under  routine  conditions  (Materials  and 
Methods),  had  little effect  on  their GVHD  potency;  such treatment  killed  _>95%  of 
the Thy-I + cells in the cell suspension. However, subjecting the cells to two consecutive 
treatments  with anti-Lyt-1.1  antibody  plus C' did cause an appreciable  reduction  in 
potency, manifested  by lower mortality  and  increased MST.  Table  II also shows that 
treating CBA  LN  cells with anti-Ia  antibody,  either broad  spectrum  anti-Ia  k  (A.TH 
anti-A.TL)  antiserum  or  a  mixture  of monoclonal  anti-I-A  k  (anti-Ia.2  +  anti-Ia. 17) ROBERT KORNGOLD AND JONATHAN SPRENT  877 
and  anti-I-E  k  (anti-Ia.7)  antibodies,  failed  to  reduce  the  incidence  of GVHD.  No 
GVHD  was  observed  with  anti-Thy-l.2-treated  cells,  even  when  the  cells  were 
incubated with antibody in the absence of C'. The effector cells thus have the Thy-1 + 
Lyt-l+2  + Ia- phenotype;  there  is no apparent  requirement  for Lyt-l+2  -  cells or Ia  + 
cells. 
Collectively, the data in Tables I and II suggest that I region-restricted cells do not 
participate  demonstrably in GVHD  to minor HA and thus favor the view that  the 
K/D-restricted subsets are the sole effector cells. 
Nature of Cells Presenting Minor HA during Negative Selection.  Studies on the generation 
of anti-viral cytotoxic responses in vivo have suggested that H-2-restricted presentation 
of antigen  is controlled by marrow-derived cells  (11). To examine whether marrow- 
derived cells control the presentation of minor HA, negative selection was studied in 
three types of H-2-semiallogeneie  BM chimeras:  (a)  supralethally  irradiated  (1,000- 
1,100 rad)  (B6 ×  CBA)Fz mice reconstituted with T  cell-depleted  B10 marrow (B10 
FI chimeras);  (b)  irradiated  (B6 ×  CBA)F1 mice injected with a  mixture of CBA 
and  B10  marrow  cells  (CBA  +  B10 ~  Fz  chimeras),  and  (c) irradiated  B6  mice 
reconstituted with [B6 ×  C3H/He  (H-2k)]F1 marrow (Fz ---~ B6 chimeras). To ensure 
maximum repopulation with donor-derived cells, the chimeras were left for 6-12 mo 
after reconstitution and then re-irradiated  (850 rad) for use as selection hosts for CBA 
T  cells.  (It should be noted that in terms of GVHD elicited by CBA T  cells, B6 and 
B10  are  indistinguishable,  although  these  strains  differ  by  at  least  one  minor  H 
antigen  [1]). 
As shown in Fig. 2, the capacity ofCBA T  cells to kill B10.BR mice was unimpaired 
after filtration through B10 mice but abolished after filtration through (B6 ×  CBA)FI 
mice. In marked contrast to this complete selection observed in normal (B6 ×  CBA)F1 
mice,  no  selection  occurred  when  CBA  T  cells  were  filtered  through  BI0  ~  F1 
chimeras; selection was complete, however, with filtration through F1 ~  B6 chimeras. 
These findings imply that marrow-derived cells play a  mandatory role in presenting 
minor HA during T  cell selection. 
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Era.  2.  Nature of cells presenting minor HA during negative selection.  The data show mortalitY 
in irradiated  BI0.BR mice given T cell-depleted CBA BM plus 10  s CBA T cells filtered through 
various BM chimeras (F1 --* B6, B10 ~  Fh CBA + B10 --~ F  0 (see text) or through normal mice 
(CBA, B10, F1). MST induced by the filtered T cells were CBA, 33.2 4- 1.1 d; BI0, 22.3 +  1.1 d; 
B10---* F1, 25.5 +  1.t d; CBA + B10--~ FI, 56.1 +  1.1 d (P< 0.01, cf. CBA). The data were pooled 
from four separate experiments involving a total of 20-24 mice per group. 878  H-2  RESTRICTION  OF  GRAFT-VS.-HOST  DISEASE 
Interestingly, intermediate  results were obtained when CBA T  cells were filtered 
through CBA +  B 10---* F1 chimeras. Although T  cells filtered through these chimeras 
did produce high mortality in B10.BR mice, the MST of the recipients was appreci- 
ably  prolonged  (56  d  vs.  33  d  for syngeneic  passaged  cells,  P  <  0.01).  Based  on 
previous studies  (1,  4),  this prolongation of MST probably signifies a  5- to  10-fold 
reduction in the potency of the filtered T  cells. The significance of this finding will be 
discussed later. 
Target Cells  for GVHD.  To examine whether marrow-derived cells present antigen 
during the effector stage of GVHD, T  cells were transferred to re-irradiated CBA ---* 
B10.BR and B 10.BR---* CBA chimeras. The chimeras were prepared by transferring 
107 anti-Thy-1-treated marrow cells into 750-820 rad irradiated mice. When tested at 
4-8 mo post-reconstitution, the content of host-derived cells in such chimeras ranges 
from 0  to  10% (1).  To examine their susceptibility to GVHD at 6 mo post-reconsti- 
tution,  the  chimeras  were  given  a  second  dose  of irradiation  (750  rad)  and  then 
injected with normal CBA or B10.BR T  cells (LN cells) plus T  cell-depleted marrow 
cells. 
As shown  in Table III, GVHD was minimal or undetectable  when CBA T  cells 
were transferred to re-irradiated B10.BR ---* CBA chimeras, or B10.BR T  cells were 
transferred  to  CBA  ~  B10.BR  chimeras;  note  that  in  both  situations  only  the 
lymphohematopoietic system and not the radio-resistant host stroma were allogeneie 
with  respect  to  the  donor  T  cells.  In  the  reciprocal  situation,  severe  GVHD  was 
observed, i.e., with CBA T  cells transferred to CBA ~  B10.BR chimeras or B10.BR 
T  cells  to  B10.BR  ---* CBA  chimeras.  The  implications  of these  findings  will  be 
discussed. 
Discussion 
The data on the effects of double negative selection  (Fig.  1)  would seem to argue 
strongly that discrete subgroups of K- and D-restricted (or K- and D-end-restricted) 
TABLE  III 
Lethal GVHD in Re-Irradiated Chimeras aj~er Transfer of Donor or Host LN Cells plus Marrow 
Cells transferred to re-irradiated  Mortality 
chimeras*  Re-irradiated chimeras 
LN  BM  Dead/total  MST ±  SE 
d 
--  ~  CBA ---* 750 rad B10.BR  7/7  13.6 ±  1.1 
--  CBA  CBA---*  750 rad BI0.BR  1/6  >100.0 
--  B10.BR  CBA ~  750 rad B10.BR  0/3  >100.0 
CBA  CBA  CBA---*  750 rad B10.BR  5/6  17.6 ±  1.6 
B10.BR  B10.BR  CBA---*  750 rad B10.BR  3/12  >100.0 
--  B10.BR  B10.BR ~  750 rad CBA  1/6  >100.0 
CBA  CBA  B10.BR --*  750 rad CBA  1/6  >100.0 
B10.BR  B10.BR  B10.BR --*  750 rad CBA  6/6  12.2 +  1.1 
B10.BR  B10.BR  B10.BR---* 820 rad CBA  6/6  19.4 ±  1.0 
--  B10.BR  CBA ---* 750 rad CBA  1/9  >100.0 
B10.BR  B10.BR  CBA--* 750 rad CBA  9/9  15.9 +  1.1 
* Chimeras were prepared by transferring 5  ×  106 anti-Thy-1.2 +  C'-treated marrow cells into irradiated 
(750 or 820 rad)  mice and then left for 26 mo. At this stage the chimeras were exposed to 750 rad and 
then received BM cells (anti-Thy-l.2 +  C'-treated)  ±  LN cells (107 viable cells) 6 h  later. ROBERT KORNGOLD AND JONATHAN SPRENT  879 
T  cells are the main effector cells for the production of lethal GVHD to minor HA. 
Two approaches suggested that I-restricted T  cells per se cannot elicit lethal GVHD: 
(a)  T  cells filtered through minor HA-different K/D-matched, I-mismatched hosts 
failed to cause GVHD (Table I), and (b) no GVHD was observed with T cells depleted 
of Lyt-2  + cells (Table II). In terms of H-2 restriction and Lyt phenotype, the T  cells 
that cause GVHD to minor HA in vivo appears to be indistinguishable  from CTL 
responding to minor HA in vitro (12, 13). Hence, it is tempting to conclude that CTL 
are  the  effector cells  for  GVHD.  To  prove  this  point,  however,  would  require 
demonstrating that cloned CTL can elicit GVHD. 
Despite the inability of I-restricted T  cells per se to elicit GVHD, the possibility 
that these cells might be required to provide helper function deserves careful consid- 
eration. In the ease of in vitro responses, I-restricted T  helper cells or their products 
play a  crucial role in governing CTL generation, probably by releasing the growth- 
promoting factor interleukin 2 (IL-2) (14, 15). Whether such a function is required in 
vivo is unclear. In the present context, the question centers on whether T cells depleted 
of I-restricted cells can cause GVHD. At face value, two pieces of evidence suggest 
that  depletion  of such  cells  does  not  cause  a  demonstrable  reduction  in  GVHD 
potency.  Firstly,  it  was  shown  previously  (4)  that  T  ceils  retain  strong  GVHD 
reactivity after filtration through I-matched, K/D-mismatched minor HA-different 
hosts; others have shown (16) that selection under such conditions does indeed remove 
T  helper cells (cells governing CTL generation in vitro). Secondly, T  cells exposed to 
a  single  treatment  of monoclonal  anti-Lyt-I  antibody  and  C',  which  would  be 
expected to remove T  helper cells, retained strong GVHD reactivity, despite the fact 
that  this treatment  lysed >_95% of Thy-1  ÷ T  ceils  (Table II).  It  is of interest  that 
double  treatment  with  anti-Lyt-1  antibody  did  cause  some  reduction  in  GVHD 
reactivity.  However, this  finding  is  not  surprising  when  it  is  borne  in  mind  that 
monoclonal antibodies detect at least small amounts of the Lyt-1 antigen on virtually 
all Thy-I + cells (17). 
Despite this evidence that  depletion of I-restricted T  cells fails to reduce GVHD 
reactivity, it does not necessarily follow that K/D-restricted T  cells in vivo function 
in the absence of T  cell help.  For example, one might argue that the removal of I- 
restricted T  cells in  the experiments mentioned above was not total. Alternatively, 
help (IL-2) might be provided by cells responding to other antigens, e.g., to environ- 
mental antigens;  this possibility fails to explain the strong GVHD reactivity of anti- 
Lyt-l-treated cells, i.e., a population presumably depleted of I-restricted reactivity to 
environmental antigens. Finally, one might entertain the simple notion that help for 
K/D-restricted T  cells in vivo is not provided exclusively by I-restricted cells but can 
also be expressed by a  subset of K/D-restricted cells.  This explanation fits the data 
and is supported by recent in vitro studies.  2 
In the case of I-restricted T  cells, it is well accepted that antigen is presented in 
association  with  Ia  molecules  on  a  specialized  class  of "accessory" ceils  (19).  By 
contrast, comparatively little is known about the mechanism of antigen presentation 
to K/D-restricted T  cells. In the case of minor HA, on a  priori  grounds, one might 
expect that any cell expressing foreign minor HA plus self-H-2 could induce T  cell 
2  Raulet, D. H., and M. J. Bevan. Helper  T cells for cytotoxic  lymphocytes  need not be 1-region-restricted. 
Manuscript submitted for publication. This notion is also supported by Widmer and Bach (18), who have 
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selection. However, the finding that negative selection of CBA T  cells to minor HA 
was complete in F1 ~  B6 chimeras but not detectable in B10 --* F1 chimeras (Fig. 2) 
would seem to provide strong evidence that selection reflects H-2-restricted contact 
with antigen on marrow-derived cells.  This finding complements the observations of 
Zinkernagel (11) on anti-viral CTL responses in a --* (a ×  b)F1 chimeras: whereas only 
a-restricted CTL were generated in the chimeras themselves, which  lack b-bearing 
marrow-derived cells,  sensitization  of the  chimera T  cells  on  adoptive transfer  to 
normal  F1  mice generated both a-  and  b-restricted CTL.  The  identity of the cells 
presenting antigen in these two systems is unknown. Macrophages might be involved, 
but this has yet to be proven. Although the presence of Ia  + macrophage-like cells is 
needed  during  CTL  generation  in  vitro  (20-22),  one  could  argue  that  the  main 
function ofIa  + cells here is to present antigen to T  helper cells and thereby lead to IL- 
2 production. 
The  finding  that  CBA  T  cells  underwent  partial  selection  to  minor  HA  with 
filtration through CBA +  B 10 ~  F1 chimeras is of some interest. Perhaps the simplest 
explanation is that, as a consequence of normal cell breakdown in the chimeras, the 
minor HA on the B10 cells were continuously "processed" by a  class of CBA cells, 
e.g., macrophage-like cells;  as the result of processing, the  B10 minor HA became 
aligned with H-2  h K/D molecules and thereby became immunogenic for CBA T  cells. 
This interpretation rests on the assumption that processed antigen is indeed immu- 
nogenic for K/D-restricted T  cells. The literature on this point is inconclusive. We 
(23) and others (24, 25) have concluded that recognition of processed antigen ("cross 
priming")  is involved in priming or selection of T  cells involved in anti-minor HA 
CTL responses.  However, the  key question of whether such recognition applies  to 
K/D=restricted T  cells rather than simply to I-restricted T  helper cells has yet to be 
resolved. In the case of GVHD-inducing T  cells, one might predict that if processed 
antigen is indeed immunogenic for K/D-restricted T  cells, the failure of CBA T  cells 
to undergo selection to  antigen  in  H-2-different B10  mice could  be overcome by 
adding CBA marrow-derived cells during selection. This approach has been conspic- 
uously unsuccessful, despite the injection of even massive doses of cells (3 X  10  s spleen 
cells 1 d  before filtration) (unpublished data). Although trivial explanations for this 
finding, e.g., poor homing of the  injected spleen cells, have not  been excluded, it 
might  be relevant  that  the  time available  for processing in  the  latter situation  is 
comparatively short (1-2 d). By contrast, an indefinite period is presumably available 
for  processing  in  CBA  +  B10  --~  F1  chimeras.  It  is  conceivable,  therefore,  that 
processing of minor HA in the context of K/D molecule association is either relatively 
ineffective or occurs rather slowly. Further work on this subject is needed. 
As for other forms of cellular immunity, GVHD to minor HA presumably reflects 
contact with antigen at two different stages, first, during T  cell induction and second, 
during the effector phase. As mentioned earlier, the fact that CBA T  cells failed to 
undergo negative selection to minor HA in B10 --~ F1 chimeras implies that, in the 
induction phase, T  cells ignore antigen presented on nonhematopoietic cells. During 
the  effector phase,  however,  contact  with  minor  HA  on  nonhematopoietic  cells 
appears  to  be  crucial.  Thus,  no  GVHD  was  observed  when  CBA  T  cells  were 
transferred to re-irradiated B 10.BR --~ CBA chimeras (Table III), a situation where 
the target minor HA were expressed solely on marrow-derived cells. 
This latter finding bears on the issue of the pathogenesis of GVHD. Perhaps the ROBERT  KORNGOLD  AND JONATHAN  SPRENT  881 
simplest view is that lethal GVHD is largely a reflection of invasion by pathogens as 
the  result  of damage  to  the  gut  and  respiratory tract  (this  being  the  most  likely 
explanation  for the resistance of germ-free mice to GVHD)  (26,  27).  Gut damage 
could either be a  consequence of direct destruction of epithelial cells by effector T 
cells or, alternatively, reflect a "bystander effect," i.e., indirect tissue damage resulting 
from destruction of other cells in the gut, e.g., marrow-derived cells  (28).  The fact 
that CBA T  cells killed CBA ~  B10.BR but not B10.BR ~  CBA chimeras is against 
the latter possibility. 
In summary,  the available evidence suggests  that  minor HA-specific T  cells are 
induced at the level of marrow-derived cells and  then, at  the effector phase, cause 
lethal GVHD by attacking minor HA-bearing nonhematopoietic cells.  At face value, 
this  interpretation  might  seem  inconsistent  with  the  finding  that  severe  GVHD 
occurred when CBA T  cells were transferred to CBA ~  B10.BR chimeras. How did 
T cell induction occur in these chimeras, i.e., how did the cells encounter the requisite 
association of B10 minor HA plus H-2  k on marrow-derived cells? Two points should 
be  made.  First,  unlike  the  H-2-semiallogeneic  chimeras  considered  earlier,  these 
chimeras were prepared with  only --<820 rad  and  hence were probably not  totally 
devoid of host-type marrow-derived cells, i.e., cells expressing BI0 minor HA plus H- 
2  k.  Second, even if host cells were absent  in such chimeras, processing of host-type 
minor  HA  by the  donor CBA  marrow cells  might  be  sufficient to  lead  to T  cell 
induction. 
Summary 
Evidence is presented that T cells that produce lethal graft-vs.-host disease (GVHD) 
to minor histocompatibility antigens  (minor HA) comprise discrete subgroups of H- 
2K- and H-2D-restricted T  cells; double negative selection of T  cells in irradiated H- 
2 recombinant mice was used to separate these two subgroups. No evidence could be 
found that I-restricted T  cells contributed to GVHD, either as effector cells or helper 
ceils.  The (unprimed) precursor cells for GVHD expressed the Thy-1  ÷, Lyt-1±2  +, Ia- 
phenotype. 
Studies in which H-2-semiallogeneic bone marrow chimeras were used as hosts for 
negative selection suggested  that  presentation  of minor  HA  to T  cells  during  the 
induction phase is controlled by marrow-derived cells; indirect evidence was obtained 
that these latter cells can "process" minor HA presented on H-2 different cells and 
thereby render the antigens immunogenic. 
Studies in which minor HA-different, H-2-compatible chimeras were re-irradiated 
and then injected with donor-vs.-host T cells suggested that the effector phase of lethal 
GVHD involves contact of antigen on non-marrow-derived cells. 
Received  for publication 23 November 1981. 
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